Literature DB >> 26038525

Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium.

Daniel B Kramer1, Daniel D Matlock2, Alfred E Buxton2, Nathan E Goldstein2, Carol Goodwin2, Ariel R Green2, James N Kirkpatrick2, Christopher Knoepke2, Rachel Lampert2, Paul S Mueller2, Matthew R Reynolds2, John A Spertus2, Lynne W Stevenson2, Susan L Mitchell2.   

Abstract

Entities:  

Keywords:  end-of-life care; ethics; health policy and outcomes research; implantable cardioverter–defibrillator

Mesh：

Year:  2015        PMID： 26038525      PMCID： PMC4512855          DOI： 10.1161/CIRCOUTCOMES.114.001660

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  100 in total

1.  Comparison of effectiveness of cardiac resynchronization therapy in patients <70 versus > or =70 years of age.

Authors:  Gabe B Bleeker; Martin J Schalij; Sander G Molhoek; Eric Boersma; Paul Steendijk; Ernst E van der Wall; Jeroen J Bax
Journal:  Am J Cardiol       Date:  2005-08-01       Impact factor: 2.778

2.  Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial.

Authors:  Suzanne V Arnold; Matthew R Reynolds; Yang Lei; Elizabeth A Magnuson; Ajay J Kirtane; Susheel K Kodali; Alan Zajarias; Vinod H Thourani; Philip Green; Josep Rodés-Cabau; Nirat Beohar; Michael J Mack; Martin B Leon; David J Cohen
Journal:  Circulation       Date:  2014-05-23       Impact factor: 29.690

3.  Heart failure with better ejection fraction: a modern diagnosis.

Authors:  Lynne Warner Stevenson
Journal:  Circulation       Date:  2014-05-05       Impact factor: 29.690

Review 4.  Measuring shared decision making: a review of constructs, measures, and opportunities for cardiovascular care.

Authors:  Karen R Sepucha; Isabelle Scholl
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-05-27

5.  The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.

Authors:  Matthew R Reynolds; David J Cohen; Aaron D Kugelmass; Phillip P Brown; Edmund R Becker; Steven D Culler; April W Simon
Journal:  J Am Coll Cardiol       Date:  2006-05-30       Impact factor: 24.094

6.  Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008.

Authors:  Preston M Schneider; Cara N Pellegrini; Yongfei Wang; Adam S Fein; Matthew R Reynolds; Jeptha P Curtis; Frederick A Masoudi; Paul D Varosy
Journal:  Am J Cardiol       Date:  2014-04-01       Impact factor: 2.778

7.  Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection.

Authors:  Ratika Parkash; William G Stevenson; Laurence M Epstein; William H Maisel
Journal:  Am Heart J       Date:  2006-02       Impact factor: 4.749

8.  Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.

Authors:  Ryan T Borne; Pamela N Peterson; Robert Greenlee; Paul A Heidenreich; Yongfei Wang; Jeptha P Curtis; Wendy S Tzou; Paul D Varosy; Mark S Kremers; Frederick A Masoudi
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

9.  Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II.

Authors:  Katia Noyes; Ethan Corona; Jack Zwanziger; W Jackson Hall; Hongwei Zhao; Hongkun Wang; Arthur J Moss; Andrew W Dick
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

Review 10.  Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.

Authors:  Krystina B Lewis; Dawn Stacey; Dan D Matlock
Journal:  Patient       Date:  2014       Impact factor: 3.883
View more
  10 in total

Review 1.  The State of the Science on Integrating Palliative Care in Heart Failure.

Authors:  Laura P Gelfman; Marie Bakitas; Lynne Warner Stevenson; James N Kirkpatrick; Nathan E Goldstein
Journal:  J Palliat Med       Date:  2017-05-12       Impact factor: 2.947

2.  Advance care planning and palliative care in ACHD: the healthcare providers' perspective.

Authors:  Jill M Steiner; Erwin N Oechslin; Gruschen Veldtman; Craig S Broberg; Karen Stout; James Kirkpatrick; Adrienne H Kovacs
Journal:  Cardiol Young       Date:  2020-02-14       Impact factor: 1.093

3.  Joint Shock/Death Risk Prediction Model for Patients Considering Implantable Cardioverter-Defibrillators.

Authors:  Harrison T Reeder; Changyu Shen; Alfred E Buxton; Sebastien J Haneuse; Daniel B Kramer
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-08-15

4.  Preliminary Development of an Informational Media Use Measure for Patients with Implanted Defibrillators: Toward a Model of Social-Ecological Assessment of Patient Education and Support.

Authors:  Christopher E Knoepke; Daniel D Matlock
Journal:  Health Soc Work       Date:  2017-11-01

5.  Comparative effectiveness of cardiac implantable electrical devices.

Authors:  Daniel B Kramer; Laura A Hatfield; Sharon-Lise T Normand
Journal:  Heart       Date:  2015-08-24       Impact factor: 5.994

Review 6.  Complex Care Options for Patients With Advanced Heart Failure Approaching End of Life.

Authors:  Sara E Wordingham; Colleen K McIlvennan; J Nicholas Dionne-Odom; Keith M Swetz
Journal:  Curr Heart Fail Rep       Date:  2016-02

7.  Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the National Cardiovascular Data Registry.

Authors:  Daniel B Kramer; Matthew R Reynolds; Sharon-Lise Normand; Craig S Parzynski; John A Spertus; Vincent Mor; Susan L Mitchell
Journal:  Circulation       Date:  2016-03-25       Impact factor: 29.690

8.  The Decisions, Interventions, and Goals in ImplaNtable Cardioverter-DefIbrillator TherapY (DIGNITY) Pilot Study.

Authors:  Daniel B Kramer; Daniel Habtemariam; Yaw Adjei-Poku; Michelle Samuel; Diane Engorn; Matthew R Reynolds; Susan L Mitchell
Journal:  J Am Heart Assoc       Date:  2017-09-22       Impact factor: 5.501

9.  Geographic and Temporal Variation in Cardiac Implanted Electric Devices to Treat Heart Failure.

Authors:  Laura A Hatfield; Daniel B Kramer; Rita Volya; Matthew R Reynolds; Sharon-Lise T Normand
Journal:  J Am Heart Assoc       Date:  2016-07-28       Impact factor: 5.501

10.  Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy.

Authors:  Brian P Halliday; Ankur Gulati; Aamir Ali; Simon Newsome; Amrit Lota; Upasana Tayal; Vassilios S Vassiliou; Monika Arzanauskaite; Cemil Izgi; Kaushiga Krishnathasan; Arvind Singhal; Kayla Chiew; John Gregson; Michael P Frenneaux; Stuart A Cook; Dudley J Pennell; Peter Collins; John G F Cleland; Sanjay K Prasad
Journal:  Eur J Heart Fail       Date:  2018-06-03       Impact factor: 15.534
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.